Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03633331
Brief Title: Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer

First Submitted : August 7, 2018
First Submitted that Met QC Criteria : August 15, 2018
First Posted : August 16, 2018

Results First Submitted : September 17, 2021
Results First Submitted that Met QC Criteria : September 17, 2021
Results First Posted : October 15, 2021

Last Update Submitted that Met QC Criteria : September 17, 2021
Last Update Posted : October 15, 2021